Heron Therapeutics (AXD2.F) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.09
-0.05
-0.02
0.02

Details

Expected EPS
-0.0130599
Actual EPS
-0.087066
Surprise EPS
-0.07
Surprise Percent
+566.67%

Description

Heron Therapeutics (AXD2.F) has reported earnings of -0.087066 per share for Q4 2025.

0 Comments

Share your thoughts